Publicaciones en las que colabora con JOSÉ LUIS ARIAS MEDIANO (32)

2024

  1. A maghemite/PLGA (core/shell) nanostructure that may facilitate chemotherapy and antitumor hyperthermia

    Journal of Magnetism and Magnetic Materials, Vol. 589

2023

  1. (Magnetite/poly(ε-caprolactone))/chitosan (core/shell)/shell nanocomposites with potential applications in hyperthermia cancer therapy

    Journal of Magnetism and Magnetic Materials, Vol. 588

2022

  1. Combined Magnetic Hyperthermia and Photothermia with Polyelectrolyte/Gold-Coated Magnetic Nanorods

    Polymers, Vol. 14, Núm. 22

2021

  1. Aplicación de nanocompuestos core/shell (Fe3O4/PCL) en fototerapia antitumoral

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 162-163

2020

  1. First steps in the formulation of praziquantel nanosuspensions for pharmaceutical applications

    Pharmaceutical Development and Technology, Vol. 25, Núm. 7, pp. 892-898

  2. Gemcitabine-loaded magnetically responsive poly(ε-caprolactone) nanoparticles against breast cancer

    Polymers, Vol. 12, Núm. 12, pp. 1-17

2018

  1. Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy

    Colloids and Surfaces B: Biointerfaces, Vol. 171, pp. 553-565

  2. Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines

    Journal of Pharmacy and Pharmacology, Vol. 70, Núm. 4, pp. 488-497

2017

  1. Design and characterization of a magnetite/PEI multifunctional nanohybrid as non-viral vector and cell isolation system

    International Journal of Pharmaceutics, Vol. 518, Núm. 1-2, pp. 270-280

  2. Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs

    AAPS PharmSciTech, Vol. 18, Núm. 8, pp. 3042-3052

  3. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil

    International Journal of Pharmaceutics, Vol. 516, Núm. 1-2, pp. 61-70

  4. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study

    European Journal of Pharmaceutical Sciences, Vol. 102, pp. 24-34

2015

  1. Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles

    Drug Design, Development and Therapy, Vol. 9, pp. 6433-6444

2014

  1. Particle geometry, charge, and wettability: The fate of nanoparticle-based drug vehicles. The fate of nanoparticle-based drug vehicles.

    Colloid and Interface Science in Pharmaceutical Research and Development (Elsevier Inc.), pp. 443-467

2011

  1. Engineering of an antitumor (core/shell) magnetic nanoformulation based on the chemotherapy agent ftorafur

    Colloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 384, Núm. 1-3, pp. 157-163

2010

  1. Iron/ethylcellulose (core/shell) nanoplatform loaded with 5-fluorouracil for cancer targeting

    Colloids and Surfaces B: Biointerfaces, Vol. 77, Núm. 1, pp. 111-116

2009

  1. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment

    International Journal of Pharmaceutics, Vol. 382, Núm. 1-2, pp. 270-276

  2. Kollidon® SR colloidal particles as vehicles for oral morphine delivery in pain treatment

    Colloids and Surfaces B: Biointerfaces, Vol. 70, Núm. 2, pp. 207-212

  3. Study of the stability of Kollidon® SR suspensions for pharmaceutical applications

    Colloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 338, Núm. 1-3, pp. 107-113

2008

  1. Magnetic colloids as drug vehicles

    Journal of Pharmaceutical Sciences, Vol. 97, Núm. 8, pp. 2948-2983